The Guaranteed Income and Financial Treatment Trial (G.I.F.T.T.) pairs a financial navigation program with guaranteed monthly income and evaluates its impact on cancer-related financial hardship, currently experienced by one in three patients during the course of their treatment.
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Fifty percent of gynecologic oncology patients experience financial toxicity. This intervention introduces a financial navigation program to mitigate financial toxicity and provide support for patients during treatment.
Through a partnership and joint leadership with Independence Blue Cross (IBC), Penn Medicine launched the first global, prospective episode payment for radiation oncology services in the United States in August 2019.
This program seeks to reduce the financial impact of multiple myeloma on patients and their families by providing coordinated financial navigation.
This project will evaluate both the impact of state Medicaid mandates for coverage of routine clinical-trial related costs and the impact of the ACA’s Medicaid expansion on racial and ethnic disparities in clinical trial enrollment. This research will allow for a deeper understanding of inequities in clinical trial participation as well as the impact of state and federal policies on enrollment patterns.